SCHEMBL24916293

SCHEMBL24916293

COC(=O)c1cc2c(c(-c3cn(C)nc3C(F)(F)F)c1)CCN(Cc1ccc(OC)cc1OC)C2=O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 12/20 0.57
EGLN1 Q9GZT9 3/20 0.51
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
GAA P10253 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KLKB1 P03952 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30054375 1.00 WDR5 (0.57) WDR5EGLN1HDAC3HDAC4HDAC1
SCHEMBL24886259 0.86 WDR5 (0.57) WDR5EGLN1GAA
SCHEMBL30190397 0.86 WDR5 (0.57) WDR5EGLN1GAA
SCHEMBL29923484 0.81 EGLN1 (0.62) EGLN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24916112 0.81 EGLN1 (0.62) EGLN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL30054337 0.80 EGLN1 (0.56) EGLN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL27167342 0.80 EGLN1 (0.56) EGLN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24916482 0.80 EGLN1 (0.51) EGLN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL29923666 0.80 EGLN1 (0.51) EGLN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL30054435 0.76 EGLN1 (0.51) EGLN1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 WDR5 1/4885EGLN1 1068/4885HDAC3 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.